Additional Details
-
A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
Xentria Investigative SiteDetroit MI. 48202 -
A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
Xentria Investigative SiteHouston TX. 77030 -
A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
Xentria Investigative SiteMinneapolis MN. 55455 -
A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
Xentria Investigative SiteCharlottesville VA. 22903 -
A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
Xentria Investigative SiteChicago IL. 60612 -
A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
Xentria Investigative SiteBaltimore MD. 21287 -
A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
Xentria Investigative SiteCincinnati OH. 45267 -
A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
Xentria Investigative SiteCharleston SC. 29425 -
A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
Xentria Investigative SiteBirmingham AL. 35233 -
A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
Xentria Investigative SiteIowa City IA. 52242 -
A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
Xentria Investigative SiteDenver CO. 80206 -
A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
Xentria Investigative SiteAlbany NY. 12208 -
A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
Xentria Investigative SiteJacksonville FL. 32209 -
A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
Xentria Investigative SitePhiladelphia PA. 19140 -
A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
Xentria Investigative SiteNew York NY. 10029 -
A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
Xentria Investigative SiteChicago IL. 60611 -
A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
Xentria Investigative SiteGreenville NC. 27858 -
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
UCLA Health Westwood Medical PlazaWestwood CA. 90095 -
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
aTyr Investigative SiteChicago IL. 60153 -
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
aTyr Investigative SiteSalt Lake City UT. 84112